CWRU Technology Ventures

NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair.

BiotechDeep TechHealthtechMedical Devices

HPHarold Punnett(Co-founder)inJSJerry Silver(Co-founder)William Adams(Executive Officer)PBPaul Brennan(Director, Executive Officer)inDMDaniel Mikol(Executive Officer)inAdam Rogersin

Co-investorsSCSCI Ventures

Afference develops neurotechnology that enables remote sensory perception through wearable devices, allowing people at a distance to share tactile sensations.

AI & Machine LearningDeep TechHardwareHealthtechCleveland, US

JSJacob Segil(Co-founder & CEO)inDTDustin Tyler(Co-founder & CTO)in

BoardTHTaylor Hurst(Director)inTZTrevor Zimmerman(Director)in

Co-investorsANAnthropy PartnersEVEvolution VC PartnersHAHannah Grey VenturesJOJobsOhio VenturesKOKonvoy VenturesMIMighty Capital+6 more

AlensiaXR develops holographic technology that replaces traditional cadavers in medical and dental education.

Deep TechEdTechHealthtech

MDMark Day(Chief Executive Officer)in

Co-investorsJOJobsOhio VenturesJUJumpstart Ventures

Atelerix Life Sciences develops novel respiratory therapies for drug-induced respiratory depression, respiratory disease exacerbations, and bio-defense against respiratory threats.

BiotechHealthtechMedical DevicesIndianapolis, US

David Kalergis(Executive Officer, Director, Promoter)WAWilliam Akridge(Director)

BoardPeter Barton Hutt(Director)

BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods.

BiotechHealthtechMedical DevicesCleveland, US

BIOHM sells probiotic supplements and at-home gut test kits that analyze the microbiome, with results reviewed by a microbiome-trained registered nutritionist who provides personalized diet and supplement recommendations.

Digital HealthDirect to ConsumerWellness & FitnessCleveland, US

MGMahmoud Ghannoum(Founder)inAGAfif Ghannoum(Director)inSSSam Schatz(Executive Officer)inMHMichael Haritakis(Executive Officer)inSteven Himmel(Director)

BoardBob Pavey(Director)

Co-investorsJOJobsOhio VenturesJUJumpstart VenturesMIMiddleland Capital

Amgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses.

BiotechDigital HealthHealthtechMedical DevicesThousand Oaks, US

George B. Rathmann(First CEO)

BoardWilliam K. Bowes

Co-investorsASAsset Management CompanyBOBOMMAMayfield FundUSUS Venture PartnersYSYsios Capital

Bisc Therapeutics develops Bax inhibitor therapies designed to prevent retinal cell death and preserve vision in patients with retinal degenerative diseases such as age-related macular degeneration, glaucoma, and inherited retinal disorders.

BiotechHealthtech

BONEZONE is a media platform and conference brand serving orthopedic device manufacturers with editorial content, digital publications, and industry networking focused on product development, regulatory trends, and market intelligence.

Marketing TechMedia & EntertainmentMedical Devices

Convelo Therapeutics develops remyelination-enhancing therapies that target the central nervous system's myelination pathway to repair nerve damage in people with multiple sclerosis.

BiotechDeep TechHealthtechCleveland, US

PTPaul Tesar(Co-founder (Professor, PhD))inDADrew Adams(Co-founder (Professor, PhD))inDRDerrick Rossi(Leader/Executive)inTracy Saxton(Chief Operating Officer)inEd Mok(Head of Finance)SSSamantha Stubblefield(VP of Operations and Business Development)in

Co-investorsJOJobsOhio VenturesJUJumpstart Ventures

COSMIIC develops active implantable medical devices, including its Networked Neuroprosthesis (NNP) modular implant platform that stimulates muscles and records signals to restore function for people with disability and disease.

BiotechDeep TechHealthtechMedical DevicesCleveland, US

Edifice Analytics provides software that quantifies energy and cost savings opportunities in commercial buildings using diagnostics, prognostics, and comparative analytics.

CleantechData & InfrastructureEnterprise SoftwareCleveland, US

Alexis Abramson(Co-founder / Senior Technical Advisor)Roger French(Co-founder / CTO)DGDave Gordon(CEO)in

Medtronic designs and develops medical technology for treating complex diseases.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investors8V8VCELElevate VenturesMEMenlo VenturesOAOak Investment PartnersPFPfizer Venture InvestmentsQUQuesta Capital+5 more

Folio Photonics develops optical storage media using multi-layer read/write materials science to provide enterprise-scale, immutable active archive storage.

Data & InfrastructureDeep TechNew MaterialsSolon, US

Kenneth D. Singer(Executive Officer, Director)SJSteven J. Santamaria(Executive Officer, Director)inRonald B. Richard(Director)Robert D. Pavey(Director)Felix Brueck(Director)

Co-investorsJOJobsOhio VenturesMAMaterial ImpactRERefinery VentureFOForte Ventures

Galvanix develops a proprietary sustainable metal reduction process for producing rare earth permanent magnets, addressing the environmental concerns of China-dominated production methods and enabling domestic manufacturing.

Advanced ManufacturingCleantechNew Materials

Global Health Metrics provides population health analytics and risk assessment tools for health plans, employers, and healthcare providers.

Data & InfrastructureEnterprise SoftwareHealthtech

Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders.

BiotechMedical Devices

ASAnirban Sen Gupta(CTO)MBMichael Bruckman(CEO)inMNMatthew Neal(CMO)CPChrista Pawlowski(COO and EVP of R&D)TPTimothy Pelura(Executive Chair)

Co-investorsTATachyon Ventures

Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants.

Digital HealthHealthtechMedical DevicesPortland, US

PWPatricia White Seminario(Executive Officer, Director, Promoter)PGPeter Galen(Chief Innovation Officer, Co-Founder)inPWPatti White(Chief Executive Officer, Co-Founder)inDaren Bledsoe(Sr. VP, Engineering & Operations)inGVGerrit van Roekel(VP, Business Development)inUGUmut Gurkan(Chief Scientist, Microfluidics)in

Co-investorsELElevate CapitalPOPortland Seed FundIDIdeaship

Light-Handed is developing diagnostic technology to improve the diagnosis of middle ear effusion (MEE), applying biomedical optics to medical device development.

Deep TechHardwareHealthtechMedical Devices

SBSteven Burns(Chief Executive Officer)inBrecken Blackburn(Chief Science Officer)inMatt McPheeters(Chief Technology Officer)in

Co-investorsJUJumpStart Equity

Luminary Therapeutics is a clinical-stage biotech developing allogeneic CAR-T cell therapies built on its Gamma 2.0+ platform to treat solid tumors, B-cell malignancies, and B-cell-mediated autoimmune diseases.

AI & Machine LearningBiotechHealthtechMinneapolis, US

David Largaespada(Executive Officer, Director, Promoter)JLJeff Liter(Executive Officer, Director, Promoter)James Haymaker(Director, Promoter)

BoardJRJeff Ross(Director)JWJohn Wells(Director)TLTracey Lodie(Director)

MT develops cancer-specific molecular imaging agents (probes) targeting a common oncoprotein in the tumor microenvironment, intended for use with imaging modalities such as CT, PET, MRI, SPECT and ultrasound.

BiotechHealthtechMedical DevicesOhio, US

Audrey Carballo

Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.

BiotechHealthtechMedical DevicesWellington, US

NeoProteomics provides contract research services in structural mass spectrometry and hydroxyl radical protein footprinting, generating structural information on protein-based pharmaceuticals for drug discovery and medicinal chemistry.

BiotechDeep Tech

Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.

BiotechHealthtechMedical DevicesAliso Viejo, US

David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)JJJon J. Snyder(Director, President, Secretary and CEO)in

BoardJEJoyce Erony(Director)inWilliam Harrington(Director)

Co-investorsAMAmzak HealthAPAPERTURE Venture PartnersISiSelect FundJOJobsOhio VenturesJUJumpstart VenturesRIRiverVest Venture Partners+6 more

Picture Health develops AI tools that analyze routine radiology and pathology images to quantify biological properties of tumors for precision oncology.

AI & Machine LearningBiotechHealthtech

Co-investorsCICintrifuse CapitalJOJobsOhio VenturesRERefinery Venture

RoadPrintz builds a robotic system mounted on a truck that scans and paints detailed pavement markings such as turn arrows, stop bars, and crosswalks.

Construction TechHardwareRobotics

Symphony Robotics develops investigational robotic technology for healthcare applications.

Medical DevicesRobotics

Mordechai (Moty) Avisar(Founder)in

Synapse Biomedical develops and commercializes neurostimulation medical devices, including the NeuRx Diaphragm Pacing System (DPS), which uses electrical stimulation of the diaphragm to treat chronic respiratory insufficiency in patients with spinal cord injuries and ALS.

BiotechDigital HealthHealthtechMedical DevicesHarrisburg, US

RPRaymond P Onders(Director)Anthony R. Ignagni(Co-founder, President & CEO)Moustapha Diop(Chief Operating Officer)Kiyotaka Mori(Director)John Krystowski(Director)

Co-investorsJUJumpstart Ventures

Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy.

BiotechBoston, US

HLHarvey LodishDFDaniel Fischer(Co-Founder, President and CEO, Board Member)inWLWarren Lammert(Co-Founder and Chairman of the Board)inHLHarvey Lodish, Ph.D.(Co-Founder, Chair of the SAB, and Board Member)JCJeffery Coller, Ph.D.(Scientific Co-Founder, Scientific Advisor)

Co-investorsGOGood Growth CapitalLALauder Partners

Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research.

AI & Machine LearningBiotechDeep TechMedical DevicesBeachwood, US

JJJan Jensen(Founder)inDivya Trivedi(Chief Operating Officer and Secretary)DLDavid Llewellyn(President & CEO)inJSJosh Snow(Chief Commercial Officer)inJennifer Antonchuk(Vice President of Research and Development)in

BoardMichael Kaufman(Director)

ClotChip develops a point-of-care diagnostic device that uses dielectric spectroscopy to evaluate whole-blood coagulation and assess patient bleeding risk without specialized equipment or reagents.

BiotechHealthtechMedical Devices